Vanderbilt University Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Vanderbilt University Medical Center sits in the top decile of US sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count).

677 total trials 130 currently recruiting 400 completed early-phase tilt top decile by trial count

Vanderbilt University Medical Center: 677 sponsored US clinical trials, 130 recruiting.

Vanderbilt University Medical Center sponsors 677 registered US clinical trials on ClinicalTrials.gov, 130 of them currently recruiting, and 400 completed. 70 of these trials are in Phase 3-4 (later-stage) and 127 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autonomic Failure, with 9 trials.

Top-decile sponsor footprint

Vanderbilt University Medical Center ranks in the top decile of sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 54/100

400 of 467 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

677 total, page 6 of 14

COMPLETED Phase 2

2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis

NCT05274243
COMPLETED Phase 4

Empiric Versus Selective Prevention Strategies for Kidney Stone Disease

NCT05365477
COMPLETED

Pragmatic Implementation of Mindful Awareness in Body Oriented Therapy

NCT05289024
COMPLETED NA

Mindfulness-Based Stress Reduction for Metro Nashville Public School Employees

NCT05051969
TERMINATED Phase 4

Steroid Administration for Articular Fractures of the Elbow (SAFE Trial)

NCT04738318
COMPLETED NA

Motivational Strategies To Empower African Americans To Improve Dialysis Adherence

NCT05003115
COMPLETED NA

Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?

NCT05373173
COMPLETED NA

Assessing the Impact of LIve Music in the Intensive Care Unit (ICU) to Improve Care for Critically Ill Patients

NCT03948984
COMPLETED NA

Strategies for Anticoagulation During Venovenous ECMO

NCT04997265
COMPLETED NA

Effects of a Patient Portal Intervention to Address Diabetes Care Gaps

NCT04894903
COMPLETED Early Phase 1

Cholinergic Mechanisms of Attention in Aging

NCT04756232
COMPLETED NA

Best Practice Advisory to Initiate High-Intensity Statin Therapy in Patients With Peripheral Artery Disease

NCT05166187
COMPLETED Phase 4

Randomized Trial of Sedative Choice for Intubation

NCT05277896
COMPLETED

Feasibility Of Objective Measures and Outpatient Washout in Disease Modifying Trials for Parkinson's Disease

NCT06192823
COMPLETED NA

DirEct Versus VIdeo LaryngosCopE Trial

NCT05239195
COMPLETED NA

Increasing Medication Check Participation Through Applying CT-r

NCT06231407
COMPLETED Phase 2

Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease

NCT05254418
COMPLETED NA

Pragmatic Trial Examining Oxygenation Prior to Intubation

NCT05267652
COMPLETED NA

BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity

NCT05051631
COMPLETED Phase 1

Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3

NCT05210504
COMPLETED

Multi-organ Transit Time Acquisition Using Contrast Ultrasound

NCT05135169
COMPLETED NA

Preoperative 3D Models and Shared Decision-making

NCT06625008
COMPLETED NA

Predictors of Speech Ability in Down Syndrome

NCT05016037
COMPLETED Phase 4

Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole

NCT04903353
COMPLETED NA

Postoperative Telehealth Mindfulness Intervention After Spine Surgery

NCT04648683
COMPLETED NA

A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes

NCT04118374
COMPLETED Phase 2

Levocarnitine for Dry Eye in Sjogren's Syndrome

NCT03953703
COMPLETED Phase 4

Effect of Antibiotic Choice On ReNal Outcomes (ACORN)

NCT05094154
TERMINATED Phase 1

"CHANGE COVID-19 Severity"

NCT04941703
TERMINATED NA

Investigating Biological Markers, Targets, and Intervention for Mood Disorders

NCT04632498
COMPLETED NA

Jackson Pediatric Acupressure for Opioid Tapering

NCT05025384
COMPLETED NA

Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in Schizophrenia

NCT07190352
COMPLETED Phase 1

Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension

NCT04908397
COMPLETED Phase 2

Management of Severe Acute Malnutrition in SCD, in Northern Nigeria

NCT03634488
COMPLETED NA

Cognitive Training in Survivors of Covid-19: A Randomized Trial

NCT04956887
TERMINATED Phase 4

Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery

NCT04990804
COMPLETED Phase 1

SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot

NCT04907214
COMPLETED NA

Group Depression Treatment for Autistic Youth

NCT05430022
COMPLETED NA

Telehealth Mindfulness-Based Music and Songwriting for Parents of Children With Intellectual/Developmental Disabilities

NCT04962659
COMPLETED NA

Telehealth Activity Intervention After Lumbar Spine Surgery

NCT04968821
COMPLETED NA

4DX for the Diagnosis of Constrictive Bronchiolitis

NCT04489758
COMPLETED NA

Discharge Medication Counseling in Hospitalized Children

NCT05143047
COMPLETED

Can COVID-19 Persist in Intraocular Fluid?

NCT04945850
COMPLETED NA

My Diabetes Care Mobile: A Usability Study

NCT04894916
COMPLETED NA

CARDIA-Salt Sensitivity of Blood Pressure (SSBP)

NCT04258332
COMPLETED NA

Evaluation of a Patient Portal Intervention to Address Diabetes Care Gaps

NCT04728620
COMPLETED Phase 2

Maximizing trEatment of Neurological Dysfunction Using INtravenous Guanfacine Study

NCT04742673
TERMINATED Phase 1

Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects

NCT03991299
COMPLETED Phase 4

The Impact of Perioperative Ketamine Infusion on Surgical Recovery

NCT04625283
COMPLETED NA

Post-operative Patient Positioning Device for Improvement of Post-Operative Pain

NCT04797637
← Previous Page 6 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 65
Phase 2 62
Phase 3 14
Phase 4 56

Therapeutic Areas

Autonomic Failure 9
Parkinson Disease 9
Obesity 8
Postural Tachycardia Syndrome 7
Pure Autonomic Failure 7
Multiple System Atrophy 7
Critical Illness 6
Cognitive Impairment 5
Delirium 5
Tourette Syndrome 5

What is open in the Vanderbilt University Medical Center pipeline

130 recruiting of 677 indexed (19% open); 400 completed (59%).

Phase mix: 70 late (III/IV) vs 127 early (I/II) (early-phase heavy).

Top condition: Autonomic Failure (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanderbilt University Medical Center: open-pipeline peers nationwide

Peers matched on 677 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01,0002,0003,000 12%14%16%18%20%22%24% Total trials Recruiting share Vanderbilt University Medical CenterThe Cleveland ClinicUniversity of California, DavisWeill Medical College of Cornell UniversityIcahn School of Medicine at Mount SinaiCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalMayo ClinicUniversity of South Carolina
Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 677 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Vanderbilt University Medical Center page

677 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University Medical Center or any single study.

  • 130 of Vanderbilt University Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autonomic Failure is the condition Vanderbilt University Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autonomic Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Vanderbilt University Medical Center pipeline card: 677 registered trials from official public datasets.Report a data error.